Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3699622016 | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3699624015 | Desogestrel 150 microgram and ethinyl estradiol 30 microgram oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3699625019 | Desogestrel 150 microgram and ethinylestradiol 30 microgram oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
46716901000001116 | Desogestrel 150microgram / Ethinylestradiol 30microgram tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
60255501000001115 | Ethinylestradiol 30microgram / Desogestrel 150microgram tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Is a | Ethinylestradiol 30mcg+progestogen | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Hormone | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Progesterone | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Ethinylestradiol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Estradiol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Synthetic progestogen | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Is a | Product containing estradiol in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Is a | Product containing desogestrel and ethinylestradiol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Desogestrel | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Desogestrel | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has basis of strength substance | Desogestrel | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Ethinylestradiol | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has basis of strength substance | Ethinylestradiol | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has basis of strength substance | Ethinylestradiol | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 30 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has basis of strength substance | Desogestrel | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 150 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 0.15 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength numerator value | 0.03 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has precise active ingredient | Desogestrel | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has precise active ingredient | Ethinylestradiol | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Is a | Product containing desogestrel and ethinylestradiol in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Is a | Product containing only desogestrel and ethinylestradiol in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Plays role | Contraceptive therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Desogestrel | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Ethinylestradiol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has active ingredient | Desogestrel | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Is a | Ethinylestradiol + Desogestrel | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has specific active ingredient | Desogestrel | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has specific active ingredient | Ethinylestradiol | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has dispensed dose form | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Ethinylestradiol+desogestrel 30micrograms/150micrograms tablet - product | Is a | False | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Marvelon tablets (Organon Pharma (UK) Ltd) | Is a | True | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Marvelon 150microgram/30microgram tablets (PI) (Waymade Ltd) | Is a | True | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Desogestrel 150microgram / Ethinylestradiol 30microgram tablets 63 tablet | Is pack of | False | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Marvelon tablets (PI) (Dowelhurst Ltd) | Is a | True | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Desogestrel 150microgram / Ethinylestradiol 30microgram tablets 63 tablet | Has VMP | True | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Marvelon tablets (Mawdsley-Brooks & Company Ltd) | Is a | True | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Gedarel 30microgram/150microgram tablets (Gedeon Richter (UK) Ltd) | Is a | True | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Marvelon tablets (Sigma Pharmaceuticals Plc) | Is a | True | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Marvelon tablets (Lexon (UK) Ltd) | Is a | True | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Marvelon tablets (Doncaster Pharmaceuticals Ltd) | Is a | True | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Cimizt 30microgram/150microgram tablets (Morningside Healthcare Ltd) | Is a | True | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Lestramyl 30microgram/150microgram tablets (Viatris UK Healthcare Ltd) | Is a | True | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Ethinylestradiol 30microgram / Desogestrel 150microgram tablets (AM Distributions (Yorkshire) Ltd) | Is a | False | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Ethinylestradiol 30microgram / Desogestrel 150microgram tablets (A A H Pharmaceuticals Ltd) | Is a | False | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Ethinylestradiol 30microgram / Desogestrel 150microgram tablets (Colorama Pharmaceuticals Ltd) | Is a | False | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Munalea 150microgram/30microgram tablets (Lupin (Europe) Ltd) | Is a | True | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Alenvona 150microgram/30microgram tablets (Actavis UK Ltd) | Is a | True | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Ethinylestradiol 30microgram / Desogestrel 150microgram tablets (J M McGill Ltd) | Is a | False | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Ethinylestradiol 30microgram / Desogestrel 150microgram tablets (Niche Pharma Ltd) | Is a | False | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Ethinylestradiol 30microgram / Desogestrel 150microgram tablets (Sigma Pharmaceuticals Plc) | Is a | False | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Ethinylestradiol 30microgram / Desogestrel 150microgram tablets (DE Pharmaceuticals) | Is a | False | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Ethinylestradiol 30microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) | Is a | False | Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets